Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

Medicine, Oncology, Pharmacotherapy +16

Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study group

C G Moertel, Stephen Frytak, R. G. Hahn et al. · Cancer · 1981 · 1K citations

Medicine, Oncology, Radiation Oncology +13

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.

Aimery de Gramont, J.-F. Bosset, C Milan et al. · Journal of Clinical Oncology · 1997 · 907 citations

Medicine, Oncology, Pharmacology +16

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

Bengt Glimelius, Katarina Hoffman, Per‐Olow Sjödén et al. · Annals of Oncology · 1996 · 805 citations

Medicine, Oncology, Pharmacology +12

Cancer principles and practice of oncology

Michael J. Kerin · Surgical Oncology · 1997 · 745 citations

Medicine, Oncology, Oncology Nursing +12